project id: TCGA-BRCA; case submitter id: TCGA-PL-A8LZ; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.87; age at index: 29; days to birth: -10869; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1984; age at diagnosis: 10869; ajcc pathologic m: M0; ajcc pathologic n: N2; ajcc pathologic stage: Stage IIIB; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 302.0; icd 10 code: C50.9; last known disease status: not reported; morphology: 8500/3; primary diagnosis: Infiltrating duct carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Breast, NOS; synchronous malignancy: No; tissue or organ of origin: Breast, NOS; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 157; days to sample procurement: 0; initial weight: 830.0; oct embedded: false; sample id: 421af19a-ae32-44b3-b91f-fed6a9b99de1; sample submitter id: TCGA-PL-A8LZ-01A; portion submitter id: TCGA-PL-A8LZ-01A-31; percent lymphocyte infiltration: 14.0; percent monocyte infiltration: 2.0; percent necrosis: 5.0; percent neutrophil infiltration: 2.0; percent normal cells: 2.0; percent stromal cells: 30.0; percent tumor cells: 63.0; percent tumor nuclei: 80.0; section location: Not Reported;